ChristopherBUmbrichtMD

Associate Professor of Surgery, Associate Professor of Oncology, Associate Professor of Pathology, Johns Hopkins University School of Medicine

Dr. Umbricht is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Johns Hopkins University School of MedicinePost-Doctoral Fellowship, 1995 - 1999
Johns Hopkins UniversityPh.D., Molecular Biology & Genetics, 1987 - 1995
Johns Hopkins UniversityResidency, Internal Medicine, 1985 - 1987
University of Basel Faculty of MedicineClass of 1982

PubMed

Multimodal genome-wide survey of progressing and non-progressing breast ductal carcinoma in-situ.
Marija Debeljak, Soonweng Cho, Bradley M Downs, Michael Considine, Brittany Avin-McKelvey
Breast Cancer Research. 2024-12-04
6 citations
miR-210 Expression Is Strongly Hypoxia-Induced in Anaplastic Thyroid Cancer Cell Lines and Is Associated with Extracellular Vesicles and Argonaute-2.
Bonita H Powell, Andrey Turchinovich, Yongchun Wang, Olesia Gololobova, Dominik Buschmann
International Journal of Molecular Sciences. 2023-02-24
6 citations
Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial.
Kala Visvanathan, Leslie Cope, Mary Jo Fackler, Michael Considine, Lori Sokoll
Clinical Cancer Research. 2023-02-16

Assessing Quality of Life After ThyroidectomyFebruary 20th, 2019
Is NIFTP Truly a Non–Thyroid Cancer Diagnosis?February 20th, 2019
Media Advisory: Young Age Associated with Worse Prognosis in Specific Breast Cancer SubtypeDecember 10th, 2018
Join now to see all